
DOI . ORG {
}
Title[redir]:
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment | Cancer Immunology, Immunotherapy
Description:
Immune checkpoint blockade enhances antitumor responses, but can also lead to severe immune-related adverse events (IRAE). To avoid unnecessary exposure to these potentially hazardous agents, it is important to identify biomarkers that correlate with clinical activity and can be used to select patients that will benefit from immune checkpoint blockade. To understand the consequences of CTLA-4 blockade and identify biomarkers for clinical efficacy and/or survival, an exploratory T cell monitoring study was performed in a phase I/II dose escalation/expansion trial (n = 28) of combined Prostate GVAX/ipilimumab immunotherapy. Phenotypic T cell monitoring in peripheral blood before and after Prostate GVAX/ipilimumab treatment revealed striking differences between patients who benefited from therapy and patients that did not. Treatment-induced rises in absolute lymphocyte counts, CD4+ T cell differentiation, and CD4+ and CD8+ T cell activation were all associated with clinical benefit. Moreover, significantly prolonged overall survival (OS) was observed for patients with high pre-treatment frequencies of CD4+CTLA-4+, CD4+PD-1+, or differentiated (i.e., non-naive) CD8+ T cells or low pre-treatment frequencies of differentiated CD4+ or regulatory T cells. Unsupervised clustering of these immune biomarkers revealed cancer-related expression of CTLA-4+ in CD4+ T cells to be a dominant predictor for survival after Prostate GVAX/ipilimumab therapy and to thus provide a putative and much-needed biomarker for patient selection prior to therapeutic CTLA4 blockade.
Matching Content Categories {📚}
- Science
- Health & Fitness
- Education
Content Management System {📝}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of doi.org audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {💸}
We don't see any clear sign of profit-making.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org could be getting rich in stealth mode, or the way it's monetizing isn't detectable.
Keywords {🔍}
article, google, scholar, cancer, pubmed, cas, prostate, blockade, patients, cell, cells, ctla, immunotherapy, clin, survival, regulatory, van, allison, oncol, metastatic, clinical, immunol, ipilimumab, melanoma, res, usa, lowy, antigen, small, treatment, eertwegh, phase, trial, med, weber, effector, privacy, cookies, content, analysis, gvaxipilimumab, santegoets, hege, blomberg, scheper, gruijl, immune, checkpoint, biomarkers, castrationresistant,
Topics {✒️}
poxviral-based psa-targeted immunotherapy month download article/chapter nj/bristol-myers squibb company prostate gvax/ipilimumab treatment castration-resistant prostate cancer prostate gvax/ipilimumab therapy hormone-refractory prostate cancer high pre-treatment frequencies patient selection prior anti-cytotoxic t-lymphocyte antigen-4 allogeneic cellular immunotherapy article cancer immunology hormone-naive prostate cancer bristol-myers squibb employee low pre-treatment frequencies jean-marie cuillerot van den eertwegh cancer immunotherapy cd8-positive related subjects anti-ctla-4 antibodies full article pdf immune checkpoint blockade progressive prostate cancer prostate cancer foundation immune checkpoint proteins human anti-ctla-4 autoimmune adverse events advanced prostate cancer asco meeting abstract privacy choices/manage cookies bristol-myers squibb anti-ctla4 antibody t-cell inhibition helper cell responses single-cell analysis ctla-4 blockade synergizes preoperative ctla-4 blockade tumour immunotherapy dose-dependent fashion cancer–preclinical background cancer vaccine failure dutch cancer society kantoff pw presurgical clinical trial cells cd4-positive van moorselaar rj experimental mammary carcinoma immunotherapy article de gruijl td cell intrinsic mechanisms
Schema {🗺️}
WebPage:
mainEntity:
headline:T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
description:Immune checkpoint blockade enhances antitumor responses, but can also lead to severe immune-related adverse events (IRAE). To avoid unnecessary exposure to these potentially hazardous agents, it is important to identify biomarkers that correlate with clinical activity and can be used to select patients that will benefit from immune checkpoint blockade. To understand the consequences of CTLA-4 blockade and identify biomarkers for clinical efficacy and/or survival, an exploratory T cell monitoring study was performed in a phase I/II dose escalation/expansion trial (n = 28) of combined Prostate GVAX/ipilimumab immunotherapy. Phenotypic T cell monitoring in peripheral blood before and after Prostate GVAX/ipilimumab treatment revealed striking differences between patients who benefited from therapy and patients that did not. Treatment-induced rises in absolute lymphocyte counts, CD4+ T cell differentiation, and CD4+ and CD8+ T cell activation were all associated with clinical benefit. Moreover, significantly prolonged overall survival (OS) was observed for patients with high pre-treatment frequencies of CD4+CTLA-4+, CD4+PD-1+, or differentiated (i.e., non-naive) CD8+ T cells or low pre-treatment frequencies of differentiated CD4+ or regulatory T cells. Unsupervised clustering of these immune biomarkers revealed cancer-related expression of CTLA-4+ in CD4+ T cells to be a dominant predictor for survival after Prostate GVAX/ipilimumab therapy and to thus provide a putative and much-needed biomarker for patient selection prior to therapeutic CTLA4 blockade.
datePublished:2012-08-10T00:00:00Z
dateModified:2012-08-10T00:00:00Z
pageStart:245
pageEnd:256
sameAs:https://doi.org/10.1007/s00262-012-1330-5
keywords:
Ipilimumab
Prostate GVAX
Biomarker
Patient selection
Survival prediction
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1330-5/MediaObjects/262_2012_1330_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1330-5/MediaObjects/262_2012_1330_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1330-5/MediaObjects/262_2012_1330_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1330-5/MediaObjects/262_2012_1330_Fig4_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:62
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Saskia J. A. M. Santegoets
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Anita G. M. Stam
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Sinéad M. Lougheed
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Helen Gall
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Petra E. T. Scholten
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Martine Reijm
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Karin Jooss
affiliation:
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Natalie Sacks
affiliation:
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Kristen Hege
affiliation:
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Israel Lowy
affiliation:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company
address:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
type:PostalAddress
type:Organization
type:Person
name:Jean-Marie Cuillerot
affiliation:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company
address:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
type:PostalAddress
type:Organization
type:Person
name:B. Mary E. von Blomberg
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Rik J. Scheper
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Alfons J. M. van den Eertwegh
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Winald R. Gerritsen
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Tanja D. de Gruijl
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
description:Immune checkpoint blockade enhances antitumor responses, but can also lead to severe immune-related adverse events (IRAE). To avoid unnecessary exposure to these potentially hazardous agents, it is important to identify biomarkers that correlate with clinical activity and can be used to select patients that will benefit from immune checkpoint blockade. To understand the consequences of CTLA-4 blockade and identify biomarkers for clinical efficacy and/or survival, an exploratory T cell monitoring study was performed in a phase I/II dose escalation/expansion trial (n = 28) of combined Prostate GVAX/ipilimumab immunotherapy. Phenotypic T cell monitoring in peripheral blood before and after Prostate GVAX/ipilimumab treatment revealed striking differences between patients who benefited from therapy and patients that did not. Treatment-induced rises in absolute lymphocyte counts, CD4+ T cell differentiation, and CD4+ and CD8+ T cell activation were all associated with clinical benefit. Moreover, significantly prolonged overall survival (OS) was observed for patients with high pre-treatment frequencies of CD4+CTLA-4+, CD4+PD-1+, or differentiated (i.e., non-naive) CD8+ T cells or low pre-treatment frequencies of differentiated CD4+ or regulatory T cells. Unsupervised clustering of these immune biomarkers revealed cancer-related expression of CTLA-4+ in CD4+ T cells to be a dominant predictor for survival after Prostate GVAX/ipilimumab therapy and to thus provide a putative and much-needed biomarker for patient selection prior to therapeutic CTLA4 blockade.
datePublished:2012-08-10T00:00:00Z
dateModified:2012-08-10T00:00:00Z
pageStart:245
pageEnd:256
sameAs:https://doi.org/10.1007/s00262-012-1330-5
keywords:
Ipilimumab
Prostate GVAX
Biomarker
Patient selection
Survival prediction
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1330-5/MediaObjects/262_2012_1330_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1330-5/MediaObjects/262_2012_1330_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1330-5/MediaObjects/262_2012_1330_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1330-5/MediaObjects/262_2012_1330_Fig4_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:62
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Saskia J. A. M. Santegoets
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Anita G. M. Stam
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Sinéad M. Lougheed
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Helen Gall
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Petra E. T. Scholten
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Martine Reijm
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Karin Jooss
affiliation:
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Natalie Sacks
affiliation:
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Kristen Hege
affiliation:
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Israel Lowy
affiliation:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company
address:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
type:PostalAddress
type:Organization
type:Person
name:Jean-Marie Cuillerot
affiliation:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company
address:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
type:PostalAddress
type:Organization
type:Person
name:B. Mary E. von Blomberg
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Rik J. Scheper
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Alfons J. M. van den Eertwegh
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Winald R. Gerritsen
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Tanja D. de Gruijl
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:62
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company
address:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
type:PostalAddress
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company
address:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Saskia J. A. M. Santegoets
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
name:Anita G. M. Stam
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Sinéad M. Lougheed
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Helen Gall
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Petra E. T. Scholten
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Martine Reijm
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Karin Jooss
affiliation:
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
type:Organization
name:Natalie Sacks
affiliation:
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
type:Organization
name:Kristen Hege
affiliation:
name:Cell Genesys Inc.
address:
name:Cell Genesys Inc., South San Francisco, USA
type:PostalAddress
type:Organization
name:Israel Lowy
affiliation:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company
address:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
type:PostalAddress
type:Organization
name:Jean-Marie Cuillerot
affiliation:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company
address:
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
type:PostalAddress
type:Organization
name:B. Mary E. von Blomberg
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Rik J. Scheper
affiliation:
name:VU University Medical Center
address:
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Alfons J. M. van den Eertwegh
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Winald R. Gerritsen
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Tanja D. de Gruijl
affiliation:
name:VU University Medical Center
address:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Cell Genesys Inc., South San Francisco, USA
name:Cell Genesys Inc., South San Francisco, USA
name:Cell Genesys Inc., South San Francisco, USA
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
name:Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, USA
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
name:Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(254)
- How profitable is https://link.springer.com/privacystatement?
- Learn how profitable https://link.springer.com/article/10.1007/s00262-012-1330-5/#main is on a monthly basis
- How much revenue does https://link.springer.com produce monthly?
- How much does https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s00262-012-1330-5 bring in each month?
- Financial intake of https://link.springer.com/article/10.1007/s00262-012-1330-5/#eds-c-header-nav
- What are the total earnings of https://link.springer.com/journals/?
- How much cash flow does https://www.springernature.com/gp/authors have monthly?
- Revenue of https://link.springernature.com/home/
- What is the monthly revenue of https://link.springer.com/article/10.1007/s00262-012-1330-5/#eds-c-header-popup-search?
- How much income does https://order.springer.com/public/cart have?
- How profitable is https://link.springer.com/article/10.1007/s00262-012-1330-5/?
- What's the income generated by https://link.springer.com/article/10.1007/s00262-012-1330-5/journal/262 each month?
- Earnings of https://link.springer.com/article/10.1007/s00262-012-1330-5/#citeas
- How profitable is https://link.springer.com/article/10.1007/s00262-012-1330-5/journal/262/aims-and-scope?
- Find out how much https://submission.nature.com/new-submission/262/3 earns monthly
- What's the income generated by https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Saskia_J__A__M_-Santegoets-Aff1 each month?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/#Aff1 generate monthly?
- What's https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Anita_G__M_-Stam-Aff2's gross income?
- Get to know https://link.springer.com/article/10.1007/s00262-012-1330-5/#Aff2's earnings
- Find out how much https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Sin_ad_M_-Lougheed-Aff1 earns monthly
- What's the monthly income of https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Helen-Gall-Aff1?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Petra_E__T_-Scholten-Aff2 bring in each month?
- What's the total monthly financial gain of https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Martine-Reijm-Aff2?
- Revenue of https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Karin-Jooss-Aff3
- What's the income of https://link.springer.com/article/10.1007/s00262-012-1330-5/#Aff3?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Natalie-Sacks-Aff3 net monthly?
- How much profit does https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Kristen-Hege-Aff3 generate?
- Learn how profitable https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Israel-Lowy-Aff4 is on a monthly basis
- How profitable is https://link.springer.com/article/10.1007/s00262-012-1330-5/#Aff4?
- How much money does https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Jean_Marie-Cuillerot-Aff4 generate?
- How much income does https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-B__Mary_E_-Blomberg-Aff2 have?
- How much income is https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Rik_J_-Scheper-Aff2 earning monthly?
- What is the monthly revenue of https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Alfons_J__M_-den_Eertwegh-Aff1?
- How much profit does https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Winald_R_-Gerritsen-Aff1 make?
- How much money does https://link.springer.com/article/10.1007/s00262-012-1330-5/#auth-Tanja_D_-Gruijl-Aff1 make?
- Income figures for https://link.springer.com/article/10.1007/s00262-012-1330-5/article/10.1007/s00262-012-1330-5/metrics
- What's the monthly money flow for https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00262-012-1330-5?
- What's the financial outcome of https://link.springer.com/product/springer-plus?
- How much money does https://www.springernature.com/gp/librarians/licensing/agc/journals make?
- https://link.springer.com/10.1007/978-3-030-80962-1_165-1?fromPaywallRec=true's revenue stream
- How much does https://link.springer.com/10.1007/s00262-022-03263-9?fromPaywallRec=true pull in monthly?
- Learn how profitable https://link.springer.com/10.1007/978-4-431-55031-0_18?fromPaywallRec=true is on a monthly basis
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/subjects/cancer-immunotherapy bring in each month?
- Find out how much https://link.springer.com/article/10.1007/s00262-012-1330-5/subjects/cd8-positive-t-cells earns monthly
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/subjects/cd4-positive-t-cells bring in each month?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/subjects/prostate-cancer pull in?
- How much money does https://link.springer.com/article/10.1007/s00262-012-1330-5/subjects/tumour-biomarkers make?
- How much revenue does https://link.springer.com/article/10.1007/s00262-012-1330-5/subjects/tumour-immunology produce monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20610543 net monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=Cancer%20statistics%2C%202010&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcaac.20073&volume=60&pages=277-300&publication_year=2010&author=Jemal%2CA&author=Siegel%2CR&author=Xu%2CJ&author=Ward%2CE make?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20651745?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BC3cXpt1Gju78%3D pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=Prostate%20cancer%20as%20a%20model%20for%20tumour%20immunotherapy&journal=Nat%20Rev%20Immunol&doi=10.1038%2Fnri2817&volume=10&pages=580-593&publication_year=2010&author=Drake%2CCG pull in?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20100959?
- What's the revenue for https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BC3cXktF2ltLw%3D?
- http://scholar.google.com/scholar_lookup?&title=Overall%20survival%20analysis%20of%20a%20phase%20II%20randomized%20controlled%20trial%20of%20a%20Poxviral-based%20PSA-targeted%20immunotherapy%20in%20metastatic%20castration-resistant%20prostate%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.25.0597&volume=28&pages=1099-1105&publication_year=2010&author=Kantoff%2CPW&author=Schuetz%2CTJ&author=Blumenstein%2CBA&author=Glode%2CLM&author=Bilhartz%2CDL&author=Wyand%2CM&author=Manson%2CK&author=Panicali%2CDL&author=Laus%2CR&author=Schlom%2CJ&author=Dahut%2CWL&author=Arlen%2CPM&author=Gulley%2CJL&author=Godfrey%2CWR's total income per month
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20818862 generate?
- What's the profit of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtVGlurrN?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Sipuleucel-T%20immunotherapy%20for%20castration-resistant%20prostate%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1001294&volume=363&pages=411-422&publication_year=2010&author=Kantoff%2CPW&author=Higano%2CCS&author=Shore%2CND&author=Berger%2CER&author=Small%2CEJ&author=Penson%2CDF&author=Redfern%2CCH&author=Ferrari%2CAC&author=Dreicer%2CR&author=Sims%2CRB&author=Xu%2CY&author=Frohlich%2CMW&author=Schellhammer%2CPF?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15470213 make?
- Learn how profitable https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD2cXot1Kmu7s%3D is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Docetaxel%20plus%20prednisone%20or%20mitoxantrone%20plus%20prednisone%20for%20advanced%20prostate%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa040720&volume=351&pages=1502-1512&publication_year=2004&author=Tannock%2CIF&author=De%2CWR&author=Berry%2CWR&author=Horti%2CJ&author=Pluzanska%2CA&author=Chi%2CKN&author=Oudard%2CS&author=Theodore%2CC&author=James%2CND&author=Turesson%2CI&author=Rosenthal%2CMA&author=Eisenberger%2CMA pull in monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20616956 gross monthly?
- https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BC3cXkt1CqtLo%3D's revenue stream
- How much income is http://scholar.google.com/scholar_lookup?&title=Update%20on%20options%20for%20treatment%20of%20metastatic%20castration-resistant%20prostate%20cancer&journal=Onco%20Targets%20Ther&volume=3&pages=39-51&publication_year=2010&author=Vishnu%2CP&author=Tan%2CWW earning monthly?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15771580?
- http://scholar.google.com/scholar_lookup?&title=The%20B7%20family%20revisited&journal=Annu%20Rev%20Immunol&doi=10.1146%2Fannurev.immunol.23.021704.115611&volume=23&pages=515-548&publication_year=2005&author=Greenwald%2CRJ&author=Freeman%2CGJ&author=Sharpe%2CAH income
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21074057 generate monthly?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BC3cXhsVWrtbfI generate monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Immune%20checkpoint%20proteins%3A%20a%20new%20therapeutic%20paradigm%20for%20cancer%E2%80%93preclinical%20background%3A%20CTLA-4%20and%20PD-1%20blockade&journal=Semin%20Oncol&doi=10.1053%2Fj.seminoncol.2010.09.005&volume=37&pages=430-439&publication_year=2010&author=Weber%2CJ?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16730267 generate monthly?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD1cXhsVCju74%3D gross monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Checkpoint%20blockade%20in%20cancer%20immunotherapy&journal=Adv%20Immunol&doi=10.1016%2FS0065-2776%2806%2990008-X&volume=90&pages=297-339&publication_year=2006&author=Korman%2CAJ&author=Peggs%2CKS&author=Allison%2CJP produce monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18759925
- What are the earnings of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD1cXhtF2qurnL?
- Profit of http://scholar.google.com/scholar_lookup?&title=Cell%20intrinsic%20mechanisms%20of%20T-cell%20inhibition%20and%20application%20to%20cancer%20therapy&journal=Immunol%20Rev&doi=10.1111%2Fj.1600-065X.2008.00649.x&volume=224&pages=141-165&publication_year=2008&author=Peggs%2CKS&author=Quezada%2CSA&author=Allison%2CJP
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20525992
- https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtVCrtrbN's financial summary
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Improved%20survival%20with%20ipilimumab%20in%20patients%20with%20metastatic%20melanoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1003466&volume=363&pages=711-723&publication_year=2010&author=Hodi%2CFS&author=O%E2%80%99Day%2CSJ&author=McDermott%2CDF&author=Weber%2CRW&author=Sosman%2CJA&author=Haanen%2CJB&author=Gonzalez%2CR&author=Robert%2CC&author=Schadendorf%2CD&author=Hassel%2CJC&author=Akerley%2CW&author=Eertwegh%2CAJ&author=Lutzky%2CJ&author=Lorigan%2CP&author=Vaubel%2CJM&author=Linette%2CGP&author=Hogg%2CD&author=Ottensmeier%2CCH&author=Lebbe%2CC&author=Peschel%2CC&author=Quirt%2CI&author=Clark%2CJI&author=Wolchok%2CJD&author=Weber%2CJS&author=Tian%2CJ&author=Yellin%2CMJ&author=Nichol%2CGM&author=Hoos%2CA&author=Urba%2CWJ
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17363537
- What's the financial intake of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD2sXivV2gtLs%3D?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=A%20pilot%20trial%20of%20CTLA-4%20blockade%20with%20human%20anti-CTLA-4%20in%20patients%20with%20hormone-refractory%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-2318&volume=13&pages=1810-1815&publication_year=2007&author=Small%2CEJ&author=Tchekmedyian%2CNS&author=Rini%2CBI&author=Fong%2CL&author=Lowy%2CI&author=Allison%2CJP?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18049334 each month?
- What's the financial gain of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtlGqs7fO?
- How much does http://scholar.google.com/scholar_lookup?&title=Ipilimumab%20%28anti-CTLA4%20antibody%29%20causes%20regression%20of%20metastatic%20renal%20cell%20cancer%20associated%20with%20enteritis%20and%20hypophysitis&journal=J%20Immunother&doi=10.1097%2FCJI.0b013e318156e47e&volume=30&pages=825-830&publication_year=2007&author=Yang%2CJC&author=Hughes%2CM&author=Kammula%2CU&author=Royal%2CR&author=Sherry%2CRM&author=Topalian%2CSL&author=Suri%2CKB&author=Levy%2CC&author=Allen%2CT&author=Mavroukakis%2CS&author=Lowy%2CI&author=White%2CDE&author=Rosenberg%2CSA pull in monthly?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19147575 earning monthly?
- How much profit is https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD1MXltFShtQ%3D%3D making per month?
- http://scholar.google.com/scholar_lookup?&title=Potentiating%20endogenous%20antitumor%20immunity%20to%20prostate%20cancer%20through%20combination%20immunotherapy%20with%20CTLA4%20blockade%20and%20GM-CSF&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-3529&volume=69&pages=609-615&publication_year=2009&author=Fong%2CL&author=Kwek%2CSS&author=O%E2%80%99Brien%2CS&author=Kavanagh%2CB&author=McNeel%2CDG&author=Weinberg%2CV&author=Lin%2CAM&author=Rosenberg%2CJ&author=Ryan%2CCJ&author=Rini%2CBI&author=Small%2CEJ's financial summary
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12682289 generate?
- What's the financial gain of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD3sXjt12nsL4%3D?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Biologic%20activity%20of%20cytotoxic%20T%20lymphocyte-associated%20antigen%204%20antibody%20blockade%20in%20previously%20vaccinated%20metastatic%20melanoma%20and%20ovarian%20carcinoma%20patients&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0830997100&volume=100&pages=4712-4717&publication_year=2003&author=Hodi%2CFS&author=Mihm%2CMC&author=Soiffer%2CRJ&author=Haluska%2CFG&author=Butler%2CM&author=Seiden%2CMV&author=Davis%2CT&author=Henry-Spires%2CR&author=Macrae%2CS&author=Willman%2CA&author=Padera%2CR&author=Jaklitsch%2CMT&author=Shankar%2CS&author=Chen%2CTC&author=Korman%2CA&author=Allison%2CJP&author=Dranoff%2CG each month?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9707601's gross income?
- Earnings of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DyaK1cXlsFWiu7g%3D
- How much does http://scholar.google.com/scholar_lookup?&title=CTLA-4%20blockade%20synergizes%20with%20tumor-derived%20granulocyte-macrophage%20colony-stimulating%20factor%20for%20treatment%20of%20an%20experimental%20mammary%20carcinoma&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.95.17.10067&volume=95&pages=10067-10071&publication_year=1998&author=Hurwitz%2CAA&author=Yu%2CTF&author=Leach%2CDR&author=Allison%2CJP generate monthly?
- How much does https://link.springer.com/doi/10.1007/s00262-008-0653-8 generate monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19198837's financial summary
- How much income does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD1MXit1CitLw%3D have?
- How much does http://scholar.google.com/scholar_lookup?&title=Ipilimumab%3A%20controversies%20in%20its%20development%2C%20utility%20and%20autoimmune%20adverse%20events&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-008-0653-8&volume=58&pages=823-830&publication_year=2009&author=Weber%2CJ pull in monthly?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21150603 earns monthly
- How much revenue does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BC3MXhvVyku70%3D bring in?
- http://scholar.google.com/scholar_lookup?&title=Autoimmunity%20and%20treatment%20outcome%20in%20melanoma&journal=Curr%20Opin%20Oncol&doi=10.1097%2FCCO.0b013e328341edff&volume=23&pages=170-176&publication_year=2011&author=Bouwhuis%2CMG&author=Hagen%2CTL&author=Suciu%2CS&author=Eggermont%2CAM income
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19671877 generate?
- What's the financial gain of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtVOntrbE?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=A%20randomized%2C%20double-blind%2C%20placebo-controlled%2C%20phase%20II%20study%20comparing%20the%20tolerability%20and%20efficacy%20of%20ipilimumab%20administered%20with%20or%20without%20prophylactic%20budesonide%20in%20patients%20with%20unresectable%20stage%20III%20or%20IV%20melanoma&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-09-1024&volume=15&pages=5591-5598&publication_year=2009&author=Weber%2CJ&author=Thompson%2CJA&author=Hamid%2CO&author=Minor%2CD&author=Amin%2CA&author=Ron%2CI&author=Ridolfi%2CR&author=Assi%2CH&author=Maraveyas%2CA&author=Berman%2CD&author=Siegel%2CJ&author=O%E2%80%99Day%2CSJ?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22326922?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Combined%20immunotherapy%20with%20granulocyte-macrophage%20colony-stimulating%20factor-transduced%20allogeneic%20prostate%20cancer%20cells%20and%20ipilimumab%20in%20patients%20with%20metastatic%20castration-resistant%20prostate%20cancer%3A%20a%20phase%201%20dose-escalation%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2812%2970007-4&volume=13&pages=509-517&publication_year=2012&author=Eertwegh%2CAJ&author=Versluis%2CJ&author=Berg%2CHP&author=Santegoets%2CSJ&author=Moorselaar%2CRJ&author=Sluis%2CTM&author=Gall%2CHE&author=Harding%2CTC&author=Jooss%2CK&author=Lowy%2CI&author=Pinedo%2CHM&author=Scheper%2CRJ&author=Stam%2CAG&author=Blomberg%2CBM&author=Gruijl%2CTD&author=Hege%2CK&author=Sacks%2CN&author=Gerritsen%2CWR produce monthly?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16740763
- Earnings of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD28XltFyis7g%3D
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Phase%20I%2FII%20trial%20of%20an%20allogeneic%20cellular%20immunotherapy%20in%20hormone-naive%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-0145&volume=12&pages=3394-3401&publication_year=2006&author=Simons%2CJW&author=Carducci%2CMA&author=Mikhak%2CB&author=Lim%2CM&author=Biedrzycki%2CB&author=Borellini%2CF&author=Clift%2CSM&author=Hege%2CKM&author=Ando%2CDG&author=Piantadosi%2CS&author=Mulligan%2CR&author=Nelson%2CWG?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17606721 pull in?
- How much profit does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD2sXntFymtrg%3D make?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Granulocyte%20macrophage%20colony-stimulating%20factor%E2%80%93secreting%20allogeneic%20cellular%20immunotherapy%20for%20hormone-refractory%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-2937&volume=13&pages=3883-3891&publication_year=2007&author=Small%2CEJ&author=Sacks%2CN&author=Nemunaitis%2CJ&author=Urba%2CWJ&author=Dula%2CE&author=Centeno%2CAS&author=Nelson%2CWG&author=Ando%2CD&author=Howard%2CC&author=Borellini%2CF&author=Nguyen%2CM&author=Hege%2CK&author=Simons%2CJW make?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18309951
- How much money does http://scholar.google.com/scholar_lookup?&title=Design%20and%20end%20points%20of%20clinical%20trials%20for%20patients%20with%20progressive%20prostate%20cancer%20and%20castrate%20levels%20of%20testosterone%3A%20recommendations%20of%20the%20Prostate%20Cancer%20Clinical%20Trials%20Working%20Group&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.12.4487&volume=26&pages=1148-1159&publication_year=2008&author=Scher%2CHI&author=Halabi%2CS&author=Tannock%2CI&author=Morris%2CM&author=Sternberg%2CCN&author=Carducci%2CMA&author=Eisenberger%2CMA&author=Higano%2CC&author=Bubley%2CGJ&author=Dreicer%2CR&author=Petrylak%2CD&author=Kantoff%2CP&author=Basch%2CE&author=Kelly%2CWK&author=Figg%2CWD&author=Small%2CEJ&author=Beer%2CTM&author=Wilding%2CG&author=Martin%2CA&author=Hussain%2CM make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17327607 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Low%20levels%20of%20circulating%20invariant%20natural%20killer%20T%20cells%20predict%20poor%20clinical%20outcome%20in%20patients%20with%20head%20and%20neck%20squamous%20cell%20carcinoma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.08.5787&volume=25&pages=862-868&publication_year=2007&author=Molling%2CJW&author=Langius%2CJA&author=Langendijk%2CJA&author=Leemans%2CCR&author=Bontkes%2CHJ&author=von%20Blomberg%2CBM&author=Scheper%2CRJ&author=Eertwegh%2CAJ earn?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10537110 have monthly?
- What is the earnings of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DyaK1MXntVWntrw%3D?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Two%20subsets%20of%20memory%20T%20lymphocytes%20with%20distinct%20homing%20potentials%20and%20effector%20functions&journal=Nature&doi=10.1038%2F44385&volume=401&pages=708-712&publication_year=1999&author=Sallusto%2CF&author=Lenig%2CD&author=Forster%2CR&author=Lipp%2CM&author=Lanzavecchia%2CA?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17329235 make?
- What's the monthly money flow for https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD2sXjsleku7Y%3D?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Activation-induced%20FOXP3%20in%20human%20T%20effector%20cells%20does%20not%20suppress%20proliferation%20or%20cytokine%20production&journal=Int%20Immunol&doi=10.1093%2Fintimm%2Fdxm014&volume=19&pages=345-354&publication_year=2007&author=Allan%2CSE&author=Crome%2CSQ&author=Crellin%2CNK&author=Passerini%2CL&author=Steiner%2CTS&author=Bacchetta%2CR&author=Roncarolo%2CMG&author=Levings%2CMK?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17154262's financial summary
- Monthly income for https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtFGitL4%3D
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Transient%20expression%20of%20FOXP3%20in%20human%20activated%20nonregulatory%20CD4%2B%20T%20cells&journal=Eur%20J%20Immunol&doi=10.1002%2Feji.200636435&volume=37&pages=129-138&publication_year=2007&author=Wang%2CJ&author=Ioan-Facsinay%2CA&author=van%20d%2CV&author=Huizinga%2CTW&author=Toes%2CRE?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16617117 net monthly?
- How much revenue does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD28XksVKrtLo%3D produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Single-cell%20analysis%20of%20normal%20and%20FOXP3-mutant%20human%20T%20cells%3A%20FOXP3%20expression%20without%20regulatory%20T%20cell%20development&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0509484103&volume=103&pages=6659-6664&publication_year=2006&author=Gavin%2CMA&author=Torgerson%2CTR&author=Houston%2CE&author=DeRoos%2CP&author=Ho%2CWY&author=Stray-Pedersen%2CA&author=Ocheltree%2CEL&author=Greenberg%2CPD&author=Ochs%2CHD&author=Rudensky%2CAY rake in every month?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17582606
- What's the income generated by https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtVyktLfF each month?
- What's http://scholar.google.com/scholar_lookup?&title=CD4%28%2B%29CD25hi%20regulatory%20T-cell%20frequency%20correlates%20with%20persistence%20of%20human%20papillomavirus%20type%2016%20and%20T%20helper%20cell%20responses%20in%20patients%20with%20cervical%20intraepithelial%20neoplasia&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.22894&volume=121&pages=1749-1755&publication_year=2007&author=Molling%2CJW&author=Gruijl%2CTD&author=Glim%2CJ&author=Moreno%2CM&author=Rozendaal%2CL&author=Meijer%2CCJ&author=van%20d%2CV&author=Eertwegh%2CAJ&author=Scheper%2CRJ&author=Blomberg%2CME&author=Bontkes%2CHJ's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12663709 bring in each month?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Prognostic%20model%20for%20predicting%20survival%20in%20men%20with%20hormone-refractory%20metastatic%20prostate%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2003.06.100&volume=21&pages=1232-1237&publication_year=2003&author=Halabi%2CS&author=Small%2CEJ&author=Kantoff%2CPW&author=Kattan%2CMW&author=Kaplan%2CEB&author=Dawson%2CNA&author=Levine%2CEG&author=Blumenstein%2CBA&author=Vogelzang%2CNJ
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18818309 have monthly?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD1cXht1aqurzI bring in each month?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=CTLA-4%20blockade%20increases%20IFNgamma-producing%20CD4%C2%A0%2B%C2%A0ICOShi%20cells%20to%20shift%20the%20ratio%20of%20effector%20to%20regulatory%20T%20cells%20in%20cancer%20patients&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0806075105&volume=105&pages=14987-14992&publication_year=2008&author=Liakou%2CCI&author=Kamat%2CA&author=Tang%2CDN&author=Chen%2CH&author=Sun%2CJ&author=Troncoso%2CP&author=Logothetis%2CC&author=Sharma%2CP
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16778987
- What's the monthly money flow for https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD28XmvV2lurw%3D?
- How much does http://scholar.google.com/scholar_lookup?&title=CTLA4%20blockade%20and%20GM-CSF%20combination%20immunotherapy%20alters%20the%20intratumor%20balance%20of%20effector%20and%20regulatory%20T%20cells&journal=J%20Clin%20Invest&doi=10.1172%2FJCI27745&volume=116&pages=1935-1945&publication_year=2006&author=Quezada%2CSA&author=Peggs%2CKS&author=Curran%2CMA&author=Allison%2CJP earn?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20143434
- How much revenue does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BC3cXkvFOns7g%3D produce monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Single-institution%20experience%20with%20ipilimumab%20in%20advanced%20melanoma%20patients%20in%20the%20compassionate%20use%20setting%3A%20lymphocyte%20count%20after%202%20doses%20correlates%20with%20survival&journal=Cancer&doi=10.1002%2Fcncr.24951&volume=116&pages=1767-1775&publication_year=2010&author=Ku%2CGY&author=Yuan%2CJ&author=Page%2CDB&author=Schroeder%2CSE&author=Panageas%2CKS&author=Carvajal%2CRD&author=Chapman%2CPB&author=Schwartz%2CGK&author=Allison%2CJP&author=Wolchok%2CJD
- How much does http://scholar.google.com/scholar_lookup?&title=Association%20of%20peripheral%20blood%20absolute%20lymphocyte%20count%20%28ALC%29%20and%20clinical%20activity%20in%20patients%20%28pts%29%20with%20advanced%20melanoma%20treated%20with%20ipilimumab&journal=ASCO%20Meeting%20Abstract%20J%20Clin%20Oncol&volume=27&publication_year=2009&author=Berman%2CDM&author=Wolchok%2CJ&author=Weber%2CJ&author=Hamid%2CO&author=O%E2%80%99Day%2CS&author=Chasalow%2CSD rake in every month?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12826605 is on a monthly basis
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD3sXlsFGnt7c%3D rake in every month?
- How much does http://scholar.google.com/scholar_lookup?&title=Cancer%20regression%20and%20autoimmunity%20induced%20by%20cytotoxic%20T%20lymphocyte-associated%20antigen%204%20blockade%20in%20patients%20with%20metastatic%20melanoma&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.1533209100&volume=100&pages=8372-8377&publication_year=2003&author=Phan%2CGQ&author=Yang%2CJC&author=Sherry%2CRM&author=Hwu%2CP&author=Topalian%2CSL&author=Schwartzentruber%2CDJ&author=Restifo%2CNP&author=Haworth%2CLR&author=Seipp%2CCA&author=Freezer%2CLJ&author=Morton%2CKE&author=Mavroukakis%2CSA&author=Duray%2CPH&author=Steinberg%2CSM&author=Allison%2CJP&author=Davis%2CTA&author=Rosenberg%2CSA pull in?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16087944
- How much revenue does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD2MXhtVKgtb3L produce monthly?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Autoimmunity%20correlates%20with%20tumor%20regression%20in%20patients%20with%20metastatic%20melanoma%20treated%20with%20anti-cytotoxic%20T-lymphocyte%20antigen-4&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.06.205&volume=23&pages=6043-6053&publication_year=2005&author=Attia%2CP&author=Phan%2CGQ&author=Maker%2CAV&author=Robinson%2CMR&author=Quezado%2CMM&author=Yang%2CJC&author=Sherry%2CRM&author=Topalian%2CSL&author=Kammula%2CUS&author=Royal%2CRE&author=Restifo%2CNP&author=Haworth%2CLR&author=Levy%2CC&author=Mavroukakis%2CSA&author=Nichol%2CG&author=Yellin%2CMJ&author=Rosenberg%2CSA?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16283570
- What's http://scholar.google.com/scholar_lookup?&title=Tumor%20regression%20and%20autoimmunity%20in%20patients%20treated%20with%20cytotoxic%20T%20lymphocyte-associated%20antigen%204%20blockade%20and%20interleukin%202%3A%20a%20phase%20I%2FII%20study&journal=Ann%20Surg%20Oncol&doi=10.1245%2FASO.2005.03.536&volume=12&pages=1005-1016&publication_year=2005&author=Maker%2CAV&author=Phan%2CGQ&author=Attia%2CP&author=Yang%2CJC&author=Sherry%2CRM&author=Topalian%2CSL&author=Kammula%2CUS&author=Royal%2CRE&author=Haworth%2CLR&author=Levy%2CC&author=Kleiner%2CD&author=Mavroukakis%2CSA&author=Yellin%2CM&author=Rosenberg%2CSA's gross income?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20713164 generate?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=CTLA-4%20blockade%20following%20relapse%20of%20malignancy%20after%20allogeneic%20stem%20cell%20transplantation%20is%20associated%20with%20T%20cell%20activation%20but%20not%20increased%20levels%20of%20T%20regulatory%20cells&journal=Biol%20Blood%20Marrow%20Transplant&doi=10.1016%2Fj.bbmt.2010.08.005&volume=17&pages=682-692&publication_year=2011&author=Zhou%2CJ&author=Bashey%2CA&author=Zhong%2CR&author=Corringham%2CS&author=Messer%2CK&author=Pu%2CM&author=Ma%2CW&author=Soiffer%2CR&author=Mitrovich%2CRC&author=Lowy%2CI&author=Ball%2CED?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20460488
- Learn about the earnings of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BC3cXlvF2hsrY%3D
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Preoperative%20CTLA-4%20blockade%3A%20tolerability%20and%20immune%20monitoring%20in%20the%20setting%20of%20a%20presurgical%20clinical%20trial&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-10-0569&volume=16&pages=2861-2871&publication_year=2010&author=Carthon%2CBC&author=Wolchok%2CJD&author=Yuan%2CJ&author=Kamat%2CA&author=Ng%20Tang%2CDS&author=Sun%2CJ&author=Ku%2CG&author=Troncoso%2CP&author=Logothetis%2CCJ&author=Allison%2CJP&author=Sharma%2CP
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10899917 make?
- How much money does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD3cXkvFGiu7c%3D make?
- http://scholar.google.com/scholar_lookup?&title=Immunologic%20self-tolerance%20maintained%20by%20CD25%28%2B%29CD4%28%2B%29%20regulatory%20T%20cells%20constitutively%20expressing%20cytotoxic%20T%20lymphocyte-associated%20antigen%204&journal=J%20Exp%20Med&doi=10.1084%2Fjem.192.2.303&volume=192&pages=303-310&publication_year=2000&author=Takahashi%2CT&author=Tagami%2CT&author=Yamazaki%2CS&author=Uede%2CT&author=Shimizu%2CJ&author=Sakaguchi%2CN&author=Mak%2CTW&author=Sakaguchi%2CS's total income per month
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10899916?
- How much profit does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD3cXkvFGiu7Y%3D generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=Cytotoxic%20T%20lymphocyte-associated%20antigen%204%20plays%20an%20essential%20role%20in%20the%20function%20of%20CD25%28%2B%29CD4%28%2B%29%20regulatory%20cells%20that%20control%20intestinal%20inflammation&journal=J%20Exp%20Med&doi=10.1084%2Fjem.192.2.295&volume=192&pages=295-302&publication_year=2000&author=Read%2CS&author=Malmstrom%2CV&author=Powrie%2CF generate?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18523152?
- What are the earnings of https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD1cXpvVOktrg%3D?
- What's the income of http://scholar.google.com/scholar_lookup?&title=CTLA4%20blockade%20expands%20FoxP3%C2%A0%2B%C2%A0regulatory%20and%20activated%20effector%20CD4%C2%A0%2B%C2%A0T%20cells%20in%20a%20dose-dependent%20fashion&journal=Blood&doi=10.1182%2Fblood-2007-11-125435&volume=112&pages=1175-1183&publication_year=2008&author=Kavanagh%2CB&author=O%E2%80%99Brien%2CS&author=Lee%2CD&author=Hou%2CY&author=Weinberg%2CV&author=Rini%2CB&author=Allison%2CJP&author=Small%2CEJ&author=Fong%2CL?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17289891?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=A%20pilot%20study%20of%20CTLA-4%20blockade%20after%20cancer%20vaccine%20failure%20in%20patients%20with%20advanced%20malignancy&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-1974&volume=13&pages=958-964&publication_year=2007&author=O%E2%80%99Mahony%2CD&author=Morris%2CJC&author=Quinn%2CC&author=Gao%2CW&author=Wilson%2CWH&author=Gause%2CB&author=Pittaluga%2CS&author=Neelapu%2CS&author=Brown%2CM&author=Fleisher%2CTA&author=Gulley%2CJL&author=Schlom%2CJ&author=Nussenblatt%2CR&author=Albert%2CP&author=Davis%2CTA&author=Lowy%2CI&author=Petrus%2CM&author=Waldmann%2CTA&author=Janik%2CJE?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19903784's gross income?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtl2ktL3F generate monthly?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Partial%20CD4%20depletion%20reduces%20regulatory%20T%20cells%20induced%20by%20multiple%20vaccinations%20and%20restores%20therapeutic%20efficacy&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-09-1113&volume=15&pages=6881-6890&publication_year=2009&author=Lacelle%2CMG&author=Jensen%2CSM&author=Fox%2CBA?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19581407?
- How much money does https://link.springer.com/article/10.1007/s00262-012-1330-5/articles/cas-redirect/1:CAS:528:DC%2BD1MXps1enu7w%3D generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20CTLA-4%20on%20both%20effector%20and%20regulatory%20T%20cell%20compartments%20contributes%20to%20the%20antitumor%20activity%20of%20anti-CTLA-4%20antibodies&journal=J%20Exp%20Med&doi=10.1084%2Fjem.20082492&volume=206&pages=1717-1725&publication_year=2009&author=Peggs%2CKS&author=Quezada%2CSA&author=Chambers%2CCA&author=Korman%2CAJ&author=Allison%2CJP make?
- What's the monthly income of https://citation-needed.springer.com/v2/references/10.1007/s00262-012-1330-5?format=refman&flavour=references?
- Check the income stats for https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Saskia%20J.%20A.%20M.%20Santegoets
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Saskia%20J.%20A.%20M.%20Santegoets generate monthly?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Saskia%20J.%20A.%20M.%20Santegoets%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What are the earnings of https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Anita%20G.%20M.%20Stam?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anita%20G.%20M.%20Stam?
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anita%20G.%20M.%20Stam%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Sin%C3%A9ad%20M.%20Lougheed earn?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sin%C3%A9ad%20M.%20Lougheed
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sin%C3%A9ad%20M.%20Lougheed%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What is the monthly revenue of https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Helen%20Gall?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Helen%20Gall?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Helen%20Gall%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Petra%20E.%20T.%20Scholten make?
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Petra%20E.%20T.%20Scholten
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Petra%20E.%20T.%20Scholten%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- Get to know what's the income of https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Martine%20Reijm
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Martine%20Reijm?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Martine%20Reijm%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the profit of https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Karin%20Jooss?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Karin%20Jooss?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Karin%20Jooss%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Natalie%20Sacks bring in?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Natalie%20Sacks
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Natalie%20Sacks%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- What's the monthly money flow for https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Kristen%20Hege?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kristen%20Hege
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kristen%20Hege%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Discover the revenue of https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Israel%20Lowy
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Israel%20Lowy income
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Israel%20Lowy%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Jean-Marie%20Cuillerot's financial summary
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jean-Marie%20Cuillerot
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jean-Marie%20Cuillerot%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=B.%20Mary%20E.%20von%20Blomberg make?
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=B.%20Mary%20E.%20von%20Blomberg?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22B.%20Mary%20E.%20von%20Blomberg%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Get to know what's the income of https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Rik%20J.%20Scheper
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rik%20J.%20Scheper?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rik%20J.%20Scheper%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit does https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Alfons%20J.%20M.%20van%20den%20Eertwegh generate?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alfons%20J.%20M.%20van%20den%20Eertwegh
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alfons%20J.%20M.%20van%20den%20Eertwegh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Winald%20R.%20Gerritsen income
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Winald%20R.%20Gerritsen?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Winald%20R.%20Gerritsen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much money does https://link.springer.com/article/10.1007/s00262-012-1330-5/search?sortBy=newestFirst&dc.creator=Tanja%20D.%20de%20Gruijl generate?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tanja%20D.%20de%20Gruijl pull in monthly?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tanja%20D.%20de%20Gruijl%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Get to know https://link.springer.com/article/10.1007/s00262-012-1330-5/mailto:[email protected]'s earnings
- What's the income of https://link.springer.com/article/10.1007/s00262-012-1330-5/mailto:[email protected]?
- What's the financial intake of https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-012-1330-5/MediaObjects/262_2012_1330_MOESM1_ESM.pdf?
- What's the financial intake of https://s100.copyright.com/AppDispatchServlet?title=T%20cell%20profiling%20reveals%20high%20CD4%2BCTLA-4%2B%20T%20cell%20frequency%20as%20dominant%20predictor%20for%20survival%20after%20Prostate%20GVAX%2Fipilimumab%20treatment&author=Saskia%20J.%20A.%20M.%20Santegoets%20et%20al&contentID=10.1007%2Fs00262-012-1330-5©right=Springer-Verlag&publication=0340-7004&publicationDate=2012-08-10&publisherName=SpringerNature&orderBeanReset=true?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1007/s00262-012-1330-5?format=refman&flavour=citation generate?
- What is the earnings of https://link.springer.com/article/10.1007/s00262-012-1330-5/search?query=Ipilimumab&facet-discipline="Medicine%20%26%20Public%20Health"?
- How much revenue does https://link.springer.com/article/10.1007/s00262-012-1330-5/search?query=Prostate%20GVAX&facet-discipline="Medicine%20%26%20Public%20Health" generate?
- How much does https://link.springer.com/article/10.1007/s00262-012-1330-5/search?query=Biomarker&facet-discipline="Medicine%20%26%20Public%20Health" bring in each month?
- Discover the revenue of https://link.springer.com/article/10.1007/s00262-012-1330-5/search?query=Patient%20selection&facet-discipline="Medicine%20%26%20Public%20Health"
- What's the financial intake of https://link.springer.com/article/10.1007/s00262-012-1330-5/search?query=Survival%20prediction&facet-discipline="Medicine%20%26%20Public%20Health"?
- How much cash flow does https://link.springer.com/journals/a/1 have monthly?
- https://link.springer.com/books/a/1 income
- How much does https://link.springer.com/journals generate monthly?
- Get to know what's the income of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- What's the financial outcome of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- See how much https://www.springernature.com/gp/products makes per month
- How much does https://www.springernature.com/gp/librarians bring in each month?
- How much does https://www.springernature.com/gp/societies pull in?
- How much revenue does https://www.springernature.com/gp/partners bring in?
- How much money does https://www.springer.com/ generate?
- How much income is https://www.nature.com/ earning monthly?
- Learn how profitable https://www.biomedcentral.com/ is on a monthly basis
- How much money does https://www.palgrave.com/ make?
- How much does https://www.apress.com/ rake in every month?
- How much money does https://link.springer.com/brands/discover generate?
- Monthly income for https://www.springernature.com/gp/legal/ccpa
- What is the monthly revenue of https://www.springernature.com/gp/info/accessibility?
- https://link.springer.com/termsandconditions's total income per month
- How much income does https://support.springernature.com/en/support/home have?
- How much revenue does https://link.springer.com/legal-notice bring in?
- What's the income generated by https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations each month?
- What is the earnings of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
Emails and Hosting {✉️}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {📦}
- Crossref